Cowen initiates coverage on Tobira Therapeutics (NASDAQ: TBRA) with a Outperform rating and a price target of $21.00.Analyst Ritu Baral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE